|
ACE/Angiotension receptors
Citations 61-70 of 995 total displayed.
|
Past content
(since Jan 1999):
|
- Scientific Contributions
Angiotensin I Is Largely Converted to Angiotensin (1-7) and Angiotensin (2-10) by Isolated Rat Glomeruli
- Juan Carlos Q. Velez, Kevin J. Ryan, Caroline E. Harbeson, Alison M. Bland, Milos N. Budisavljevic, John M. Arthur, Wayne R. Fitzgibbon, John R. Raymond, and Michael G. Janech
Hypertension published March 16, 2009, doi:10.1161/HYPERTENSIONAHA.109.128819
[Abstract]
- Scientific Contributions
Defects in Cutaneous Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Production in Postural Tachycardia Syndrome
- Julian M. Stewart, Anthony J. Ocon, Debbie Clarke, Indu Taneja, and Marvin S. Medow
Hypertension published March 16, 2009, doi:10.1161/HYPERTENSIONAHA.108.127357
[Abstract]
- Scientific Contributions
Inhibition of Tumor Necrosis Factor- –Induced Interleukin-6 Expression by Telmisartan Through Cross-Talk of Peroxisome Proliferator-Activated Receptor- With Nuclear Factor  B and CCAAT/Enhancer-Binding Protein-
- Qingping Tian, Ryohei Miyazaki, Toshihiro Ichiki, Ikuyo Imayama, Keita Inanaga, Hideki Ohtsubo, Kotaro Yano, Kotaro Takeda, and Kenji Sunagawa
Hypertension published March 16, 2009, doi:10.1161/HYPERTENSIONAHA.108.126656
[Abstract]
- Scientific Contributions
Hemodynamic and Cardiac Effects of Chronic Eprosartan and Moxonidine Therapy in Stroke-Prone Spontaneously Hypertensive Rats
- Suhayla Mukaddam-Daher, Ahmed Menaouar, Pierre-Alexandre Paquette, Marek Jankowski, Jolanta Gutkowska, Marc-Antoine Gillis, Yan-Fen Shi, Angelo Calderone, and Jean-Claude Tardif
Hypertension published March 9, 2009, doi:10.1161/HYPERTENSIONAHA.108.126524
[Abstract]
- Scientific Contributions
Vascular-Protective Effects of High-Density Lipoprotein Include the Downregulation of the Angiotensin II Type 1 Receptor
- Sophie Van Linthout, Frank Spillmann, Mario Lorenz, Marco Meloni, Frank Jacobs, Marina Egorova, Verena Stangl, Bart De Geest, Heinz-Peter Schultheiss, and Carsten Tschöpe
Hypertension published March 9, 2009, doi:10.1161/HYPERTENSIONAHA.108.118919
[Abstract]
- Editorial Commentaries
RALT Specifically Halts Maladaptive Cardiac Hypertrophy: A New Kid on the Block
- Martin W. Bergmann and Laura Zelarayan
Hypertension 2009;53:454-455; published online before print as doi:10.1161/HYPERTENSIONAHA.108.125930
[Full text]
- Scientific Contributions
Attenuation of Cuff-Induced Neointimal Formation by Overexpression of Angiotensin II Type 2 Receptor-Interacting Protein 1
- Teppei Fujita, Masaki Mogi, Li-Juan Min, Jun Iwanami, Kana Tsukuda, Akiko Sakata, Hideki Okayama, Masaru Iwai, Clara Nahmias, Jitsuo Higaki, and Masatsugu Horiuchi
Hypertension published February 16, 2009, doi:10.1161/HYPERTENSIONAHA.108.128140
[Abstract]
- Editorial Commentary
RALT Specifically Halts Maladaptive Cardiac Hypertrophy. A New Kid on the Block
- Martin W. Bergmann and Laura Zelarayan
Hypertension published February 9, 2009, doi:10.1161/HYPERTENSIONAHA.108.125930
[Abstract]
- Letters to the Editor
Response to Aliskiren Therapy Will Have Minimal Effect on Intracellular Renin of Renin-Producing Cells
- Manne Krop and A.H. Jan Danser
Hypertension 2009;53:e18; published online before print as doi:10.1161/HYPERTENSIONAHA.108.126979
[Full text]
- Original Articles
Plasma Kallikrein Mediates Angiotensin II Type 1 Receptor–Stimulated Retinal Vascular Permeability
- Joanna A. Phipps, Allen C. Clermont, Sukanto Sinha, Tamie J. Chilcote, Sven-Erik Bursell, and Edward P. Feener
Hypertension 2009;53:175-181; published online before print as doi:10.1161/HYPERTENSIONAHA.108.117663
[Abstract]
[Full text]
|
|
